JNK1

Isoforms Recommended:	JNK1

By Targets:	Apoptosis (5) Autophagy (2) Casein Kinase (1) CDK (1) Cytochrome P450 (1) Discoidin Domain Receptor (1) ERK (1) Ferroptosis (1) GSK-3 (1) IRAK (1) JNK (30) MDM-2/p53 (1) Mixed Lineage Kinase (1) MNK (1) Mps1 (1) NF-κB (1) p38 MAPK (3) Raf (1) Topoisomerase (1)
By Research Areas:	Cancer (21) Cardiovascular Disease (1) Inflammation/Immunology (10) Neurological Disease (8)

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-107598

JNK Inhibitor VIII 2 Publications Verification TCS JNK 6o	JNK	Cancer
JNK Inhibitor VIII (TCS JNK 6o) is a *c-Jun N-terminal kinases (JNK-1, -2, and -3)* inhibitor with K_i values of 2 nM, 4 nM, 52 nM, respectively, and has IC₅₀ values of 45 nM and 160 nM for JNK-1 and -2, respectively ^[1].

HY-15737

DB07268

4 Publications Verification

JNK Cancer

DB07268 is a potent and selective JNK1 inhibitor with an IC₅₀ value of 9 nM.

DB07268 4 Publications Verification	JNK	Cancer
DB07268 is a potent and selective *JNK1* inhibitor with an IC₅₀ value of 9 nM.

HY-138304

CC-90001 1 Publications Verification	JNK	Inflammation/Immunology
CC-90001 is a potent, selective and orally active inhibitor of c-Jun N-terminal kinase (JNK). CC-90001 shows 12.9-fold selectivity for *JNK1* over *JNK2* in a cell-based model. CC-90001 can be used for the research of idiopathic pulmonary fibrosis ^[1] .

HY-14411

JNK-1-IN-1

JNK Cancer

JNK-1-IN-1 is a JNK-1 inhibitor. JNK-1-IN-1 also inhibits MKK7 with an IC₅₀ of 7.8μM. JNK-1-IN-1 bind to MKK7cp and acts as an inhibitor of JNK-1 ^[1].

JNK-1-IN-1	JNK	Cancer
JNK-1-IN-1 is a *JNK-1* inhibitor. JNK-1-IN-1 also inhibits MKK7 with an IC₅₀ of 7.8μM. JNK-1-IN-1 bind to MKK7cp and acts as an inhibitor of *JNK-1* ^[1].

HY-155593

JNK-1-IN-2	JNK	Inflammation/Immunology
JNK-1-IN-2 (Compound c6) is a *JNK-1* inhibitor (IC₅₀: 33.5 nM). JNK-1-IN-2 also inhibits JNK-2 and JNK-3 with IC₅₀s of 112.9 nM and 33.2 nM. JNK-1-IN-2 inhibits the phosphorylation of c-Jun. JNK-1-IN-2 reverses lung impairment. JNK-1-IN-2 can be used for research of pulmonary fibrosis ^[1].

HY-N12526

Isolappaol A	Others	Others
Isolappaol A is a natural product that can be isolated from the Arctium lappa. Isolappaol A upregulates the expression of jnk-1, which may promote longevity and stress resistance of C. elegans through the JNK-1-DAF-16 cascade ^[1].

HY-14761

Bentamapimod 5+ Cited Publications AS 602801	JNK	Cancer
Bentamapimod (AS 602801) is an ATP-competitive *JNK* inhibitor with IC₅₀ of 80 nM, 90 nM, and 230 nM for *JNK1, JNK2, and JNK3*, respectively.

HY-13275

IRAK inhibitor 1	IRAK	Inflammation/Immunology
IRAK inhibitor 1 is a potent IRAK-4 inhibitor with IC₅₀ of 216 nM, is poorly active against JNK-1 and JNK-2 with IC₅₀ of 3.801 μM, and >10 μM, respectively.

HY-15495

Tanzisertib

5+ Cited Publications

CC-930
JNK Inflammation/Immunology

Tanzisertib (CC-930) is a potent JNK1/2/3 inhibitor with IC₅₀s of 61/7/6 nM, respectively.
HY-15617

JNK-IN-7

4 Publications Verification

JNK inhibitor
JNK Cancer

JNK-IN-7 is a potent JNK inhibitor with IC₅₀ of 1.5, 2 and 0.7 nM for JNK1, JNK2 and JNK3, respectively.

Tanzisertib 5+ Cited Publications CC-930	JNK	Inflammation/Immunology
Tanzisertib (CC-930) is a potent *JNK1/2/3* inhibitor with IC₅₀s of 61/7/6 nM, respectively.

JNK-IN-7 4 Publications Verification JNK inhibitor	JNK	Cancer
JNK-IN-7 is a potent *JNK* inhibitor with IC₅₀ of 1.5, 2 and 0.7 nM for *JNK1, JNK2* and *JNK3*, respectively.

HY-12862

Mps1-IN-7	Mps1	Cancer
Mps1-IN-7 is a potent *MPS1* inhibitor (IC₅₀ of 0.020 μM) over JNK1 and JNK2 (JNK1 IC₅₀= 0.11 μM, JNK2 IC₅₀=0.22 μM). Mps1-IN-7 inhibit SW620, CAL51, Miapaca-2, RMG1 cell growth with GI₅₀ values of 0.065, 0.068, 0.25, and 0.110 μM,respectively ^[1].

HY-13319

JNK-IN-8 30+ Cited Publications JNK Inhibitor XVI	JNK	Cancer
JNK-IN-8 (JNK Inhibitor XVI) is a potent *JNK* inhibitor with IC₅₀s of 4.7 nM, 18.7 nM, and 1 nM for *JNK1, JNK2, and JNK3*, respectively ^[1].

HY-N0773

Isovitexin 3 Publications Verification Saponaretin; Homovitexin	JNK NF-κB	Inflammation/Immunology
Isovitexin is a flavonoid isolated from passion flower, Cannabis and, and the palm, possesses anti-inflammatory and anti-oxidant activities; Isovitexin acts like a *JNK1/2* inhibitor and inhibits the activation of NF-κB.

HY-P2246

JTP10-△-TATi TFA

JNK Cancer

JTP10-△-TATi TFA is a selective JNK2 peptide inhibitor, with an IC₅₀ of 92 nM, exhibiting 10-fold selectivity for JNK2 over JNK1 and JNK3 ^[1].
HY-P2247

JTP10-△-R9 TFA

JNK Cancer

JTP10-△-R9 TFA is a selective JNK2 peptide inhibitor, with an IC₅₀ of 89 nM, exhibiting 10-fold selectivity for JNK2 over JNK1 and JNK3 ^[1].

JTP10-△-TATi TFA	JNK	Cancer
JTP10-△-TATi TFA is a selective *JNK2* peptide inhibitor, with an IC₅₀ of 92 nM, exhibiting 10-fold selectivity for JNK2 over JNK1 and JNK3 ^[1].

JTP10-△-R9 TFA	JNK	Cancer
JTP10-△-R9 TFA is a selective *JNK2* peptide inhibitor, with an IC₅₀ of 89 nM, exhibiting 10-fold selectivity for JNK2 over JNK1 and JNK3 ^[1].

HY-N7394A

(-)-Zuonin A 1 Publications Verification D-Epigalbacin	JNK	Cancer
(-)-Zuonin A (D-Epigalbacin), a naturally occurring lignin, is a potent, selective *JNKs* inhibitor, with IC₅₀s of 1.7 μM, 2.9 μM and 1.74 μM for JNK1, JNK2 and JNK3, respectively ^[1].

HY-10520

CGP 57380 4 Publications Verification	MNK Apoptosis	Cancer
CGP 57380 is a cell-permeable pyrazolo-pyrimidine compound that acts as a selective inhibitor of *Mnk1* with IC₅₀ of 2.2 μM, but has no inhibitory activity against p38, JNK1, ERK1/2, PKC, or Src-like kinases.

HY-150053

JNK-IN-11	JNK	Neurological Disease
JNK-IN-11 (compound 1) is a potent *JNK* inhibitor with an IC₅₀ value of 2.2, 21.4, 1.8 µM for JNK1, JNK2, JNK3, respectively. JNK-IN-11 has the potential for the research of alzheimer and parkinson disease ^[1].

HY-107600

IQ-3 1 Publications Verification	JNK	Inflammation/Immunology
IQ-3 is a specific inhibitor of the c-Jun N-terminal kinase (JNK) family, with preference for JNK3. IQ-3 exhibits K_d values of 0.24 μM, 0.29 μM and 0.066 μM for JNK1, JNK2 and JNK3, respectively ^[1].

HY-10542

GW 5074 5+ Cited Publications	Raf Apoptosis	Cancer
GW 5074 is a potent and selective c-Raf inhibitor with IC₅₀ of 9 nM, and has no effect on the activities of JNK1/2/3, MEK1, MKK6/7, CDK1/2, c-Src, p38 MAP, VEGFR2 or c-Fms ^[1] .

HY-12041

SP600125 Maximum Cited Publications 405 Publications Verification	JNK Autophagy Apoptosis Ferroptosis	Cancer
SP600125 is an orally active, reversible, and ATP-competitive *JNK* inhibitor with IC₅₀s of 40, 40 and 90 nM for *JNK1, JNK2* and *JNK3, respectively. SP600125 is a potent ferroptosis* inhibitor. SP600125 induces the transformation of bladder cancer cells from autophagy to apoptosis ^[1] .

HY-150552

JNK3 inhibitor-2	JNK Discoidin Domain Receptor	Inflammation/Immunology Cancer
JNK3 inhibitor-2 is a potent and selective *JNK3* inhibitor with IC₅₀ values of >100, >100, 0.25 µM for JNK1, JNK2, JNK3, respectively. JNK3 inhibitor-2 shows DDR1 and EGFR (T790M, L858R) inhibition ^[1].

HY-149930

YL5084	JNK Apoptosis	Cancer
YL5084, a covalent *JNK* inhibitor, exhibits selectivity for JNK2 and JNK3 over JNK1 with IC₅₀s of 70 nM, 84 nM and 2173 nM, respectively. YL5084 exhibits JNK2-independent antiproliferative effects and induces apoptosis in a JNK2-independent manner ^[1].

HY-100233

IQ-1S free acid 1 Publications Verification	JNK	Inflammation/Immunology Cancer
IQ-1S free acid is a prospective inhibitor of NF-κB/activating protein 1 (AP-1) activity with an IC₅₀ of 2.3±0.41 μM. IQ-1S free acid has binding affinity (K_d values) in the nanomolar range for all three *JNKs with K_ds of 100 nM, 240 nM, and 360 nM for JNK3, JNK1, and JNK2*, respectively.

HY-13319G

JNK-IN-8 JNK Inhibitor XVI	JNK	Cancer
JNK-IN-8 (JNK Inhibitor XVI) (GMP) is JNK-IN-8 (HY-13319) produced by using GMP guidelines. GMP small molecules work appropriately as an auxiliary reagent for cell therapy manufacture. JNK-IN-8 is a potent *JNK* inhibitor with IC₅₀s of 4.7 nM, 18.7 nM, and 1 nM for *JNK1, JNK2, and JNK3*, respectively ^[1].

HY-149279

JNK3 inhibitor-7	JNK	Neurological Disease
JNK3 inhibitor-7 is a potent, orally active and cross the blood-brain barrier *JNK3* inhibitor with IC₅₀ values of 53, 973, 1039 nM for JNK3, JNK2, JNK1, respectively. JNK3 inhibitor-7 shows significant neuroprotective effects. JNK3 inhibitor-7 has the potential for the research of Alzheimer’s disease (AD) ^[1].

HY-149280

JNK3 inhibitor-8	JNK	Neurological Disease
JNK3 inhibitor-8 is a potent, delective, orally active and cross the blood-brain barrier *JNK3* inhibitor with IC₅₀ values of 21, 2203, >10000 nM for JNK3, JNK2, JNK1, respectively. JNK3 inhibitor-8 shows significant neuroprotective effects. JNK3 inhibitor-8 has the potential for the research of Alzheimer’s disease (AD) ^[1].

HY-N2205

Esculentoside H
Esculentoside H (EsH) is a saponin isolated from the root extract of perennial plant Phytolacca esculenta ^[1]. Esculentoside H (EH) has anti-tumor activity, the mechanism is related to the capacity for TNFrelease . Esculentoside H (EsH) suppresses colon cancer cell migration through blockage of the JNK1/2 and NF-κB signaling-mediated matrix metalloproteinases-9 (MMP-9) expression ^[1].

HY-10412

CEP-1347 KT7515	JNK Mixed Lineage Kinase MDM-2/p53	Neurological Disease
CEP-1347 is an inhibitor of the *JNK/SAPK* pathway with neuroprotective effects. CEP-1347 blocks JNK1 activation induced by members of the mixed lineage kinase (MLK) family (MLK3, MLK2, MLK1, dual leucine zipper kinase, and leucine zipper kinase). As an inhibitor of MDM4, CEP-1347 can more effectively inhibit the growth of glioma cells expressing wild-type p53 ^[1] .

HY-156182

JNK-IN-14	JNK Cytochrome P450	Cancer
JNK-IN-14 is a potent *JNK* inhibitor with IC₅₀ values of 1.81, 12.7 and 10.5 nM for JNK1, JNK2 and JNK3, respectively. JNK-IN-14 induces early-stage apoptosis. JNK-IN-14 shows cell population arrest at the G2/M phase and slightly inhibits *beclin-1* production at K562 leukemia cells relative to SP600125 (HY-12041), showing higher inhibitory ability. ^[1]

HY-N12561

Pestanoid A	ERK p38 MAPK JNK	Others
Pestanoid A is a rearranged pimarane diterpenoid osteoclastogenesis inhibitor with an IC₅₀ of 4.2 μM. Pestanoid A can be isolated from the marine mesophotic zone chalinidae sponge-associated fungus, Pestalotiopsis sp. NBUF145. Pestanoid A inhibits the receptor activator of NF-kB ligand-induced MAPK and NF-κB signaling by suppressing the phosphorylation of ERK1/2-JNK1/2-p38 MAPKs and NF-κB nuclear translocation. Pestanoid A can be used for the study of osteoporosis ^[1].

HY-151928

JNK3 inhibitor-3	JNK	Neurological Disease
JNK3 inhibitor-3 (compound 15g) is a selective, BBB permeable and orally active c-Jun N-terminal kinase 3 (JNK3) inhibitor. JNK3 inhibitor-3 has inhibitory activities to JNK1, JNK2 and JNK3 with IC₅₀ values of 147.8, 44.0 and 4.1 nM, respectively. JNK3 inhibitor-3 significantly improves the memory in mouse dementia model. JNK3 inhibitor-3 can be used for the research of Alzheimer’s disease ^[1].

HY-139254

Indirubin-3′-oxime IDR3O; I3O	CDK GSK-3 JNK	Neurological Disease
Indirubin-3′-oxime (IDR3O), a synthetic derivative of indirubin, is a potent inhibitor of cyclin-dependent kinases (CDKs) and glycogen synthase kinase 3β (GSK3β). Indirubin-3′-oxime directly inhibits the activity of all three isoforms of JNK (JNK1, JNK2, and JNK3), with IC₅₀s of 0.8 μM, 1.4 μM, and 1.0 μM, respectively. Indirubin-3′-oxime can enhance height growth via activation of Wnt/β-catenin signaling in chondrocytes ^[1] .

HY-151929

JNK3 inhibitor-4	JNK	Neurological Disease
JNK3 inhibitor-4 is a potent inhibitor of *JNK3* (IC₅₀=1.0 nM) based on 2-aryl-1-pyrimidinyl-1H-imidazole-5-yl acetonitrile. JNK3 inhibitor-4 shows excellent selectivity over other protein kinases including isoforms *JNK1* (IC₅₀=143.9 nM) and *JNK2* (IC₅₀=298.2 nM) ^[1]. JNK3 inhibitor-4 has neuroprotective effect and predicated blood-brain barrier permeability ^[1].

HY-P10141

JNK-IN-15, Cell-Permeable, Negative Control	JNK	Cancer
JNK-IN-15, Cell-Permeable, Negative Control is a negative control of JNK-IN-15, Cell-Permeable (HY-P10140). JNK-IN-15, Cell-Permeable is an inhibitor of *JNK* .

HY-N11536

erythro-Austrobailignan-6	Topoisomerase Apoptosis	Cancer
erythro-Austrobailignan-6 is an orally active anti-cancer agent. erythro-Austrobailignan-6 inhibits DNA topoisomerase I and II activity. erythro-Austrobailignan-6 induces cell apoptosis and increases phosphorylation of p38 and JNK .

HY-125838

J30-8	JNK	Neurological Disease
J30-8 is a potent and isoform-selective inhibitor of c-Jun N-terminal kinase 3 (JNK3) with an IC₅₀ of 40 nM, which 2500-fold isoform selectivity against JNK1α1 and JNK2α2. J30-8 exhibits neuroprotective activity in vitro and potential for the treatment of neurodegenerative diseases ^[1].

HY-10456

TAK-715 10+ Cited Publications	p38 MAPK Casein Kinase	Inflammation/Immunology
TAK-715 is an orally active and potent p38 MAPK inhibitor with IC₅₀s of 7.1 nM, 200 nM for p38α and p38β, respectively. TAK-715 inhibits casein kinase I (CK1δ/ε) to regulate activation of Wnt/β-catenin signaling. TAK-715 shows good significant efficacy in a rat arthritis model ^[1] .

HY-100115

TA-02 2 Publications Verification	p38 MAPK Autophagy	Cardiovascular Disease Inflammation/Immunology Cancer
TA-02, an analog of SB 203580 (HY-10256), is a p38 MAPK inhibitor with an IC₅₀ of 20 nM. TA-02 especially inhibits TGFBR-2. TA-02 exhibits similar cardiogenic properties as SB 203580 and SB 202190 (HY-10295) ^[1].

Cat. No.	Product Name	Type

HY-13319G

JNK-IN-8 (GMP) JNK Inhibitor XVI (GMP)	Fluorescent Dye
JNK-IN-8 (JNK Inhibitor XVI) (GMP) is JNK-IN-8 (HY-13319) produced by using GMP guidelines. GMP small molecules work appropriately as an auxiliary reagent for cell therapy manufacture. JNK-IN-8 is a potent *JNK* inhibitor with IC₅₀s of 4.7 nM, 18.7 nM, and 1 nM for *JNK1, JNK2, and JNK3*, respectively ^[1].

Cat. No.	Product Name	Type

HY-13319G

JNK-IN-8 (GMP) JNK Inhibitor XVI (GMP)	Biochemical Assay Reagents
JNK-IN-8 (JNK Inhibitor XVI) (GMP) is JNK-IN-8 (HY-13319) produced by using GMP guidelines. GMP small molecules work appropriately as an auxiliary reagent for cell therapy manufacture. JNK-IN-8 is a potent *JNK* inhibitor with IC₅₀s of 4.7 nM, 18.7 nM, and 1 nM for *JNK1, JNK2, and JNK3*, respectively ^[1].

Cat. No.	Product Name	Target	Research Area

HY-P2246

JTP10-△-TATi TFA

JNK Cancer

JTP10-△-TATi TFA is a selective JNK2 peptide inhibitor, with an IC₅₀ of 92 nM, exhibiting 10-fold selectivity for JNK2 over JNK1 and JNK3 ^[1].
HY-P2247

JTP10-△-R9 TFA

JNK Cancer

JTP10-△-R9 TFA is a selective JNK2 peptide inhibitor, with an IC₅₀ of 89 nM, exhibiting 10-fold selectivity for JNK2 over JNK1 and JNK3 ^[1].

JTP10-△-TATi TFA	JNK	Cancer
JTP10-△-TATi TFA is a selective *JNK2* peptide inhibitor, with an IC₅₀ of 92 nM, exhibiting 10-fold selectivity for JNK2 over JNK1 and JNK3 ^[1].

JTP10-△-R9 TFA	JNK	Cancer
JTP10-△-R9 TFA is a selective *JNK2* peptide inhibitor, with an IC₅₀ of 89 nM, exhibiting 10-fold selectivity for JNK2 over JNK1 and JNK3 ^[1].

HY-P10141

JNK-IN-15, Cell-Permeable, Negative Control	JNK	Cancer
JNK-IN-15, Cell-Permeable, Negative Control is a negative control of JNK-IN-15, Cell-Permeable (HY-P10140). JNK-IN-15, Cell-Permeable is an inhibitor of *JNK* .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-N0773

Isovitexin 3 Publications Verification Saponaretin; Homovitexin	Structural Classification Classification of Application Fields Cannabis sativa L Flavones Passifloraceae Plants Moraceae Passiflora coerulea Linn. Flavonoids Palmae Inflammation/Immunology Disease Research Fields Trachycarpus fortunei (Hook.) H. Wendl.	JNK NF-κB
Isovitexin is a flavonoid isolated from passion flower, Cannabis and, and the palm, possesses anti-inflammatory and anti-oxidant activities; Isovitexin acts like a *JNK1/2* inhibitor and inhibits the activation of NF-κB.

HY-N7394A

(-)-Zuonin A 1 Publications Verification D-Epigalbacin	Classification of Application Fields Source classification Lignans Phenylpropanoids Plants Schisandraceae Disease Research Fields Schisandra chinensis (Turcz.) Baill. Cancer	JNK
(-)-Zuonin A (D-Epigalbacin), a naturally occurring lignin, is a potent, selective *JNKs* inhibitor, with IC₅₀s of 1.7 μM, 2.9 μM and 1.74 μM for JNK1, JNK2 and JNK3, respectively ^[1].

HY-N12526

Isolappaol A	Structural Classification Source classification Lignans Phenols Polyphenols Phenylpropanoids Plants Compositae Caesalpinia magnifoliolata Metc.	Others
Isolappaol A is a natural product that can be isolated from the Arctium lappa. Isolappaol A upregulates the expression of jnk-1, which may promote longevity and stress resistance of C. elegans through the JNK-1-DAF-16 cascade ^[1].

HY-N12561

Pestanoid A	Structural Classification Microorganisms Terpenoids Source classification Diterpenoids	ERK p38 MAPK JNK
Pestanoid A is a rearranged pimarane diterpenoid osteoclastogenesis inhibitor with an IC₅₀ of 4.2 μM. Pestanoid A can be isolated from the marine mesophotic zone chalinidae sponge-associated fungus, Pestalotiopsis sp. NBUF145. Pestanoid A inhibits the receptor activator of NF-kB ligand-induced MAPK and NF-κB signaling by suppressing the phosphorylation of ERK1/2-JNK1/2-p38 MAPKs and NF-κB nuclear translocation. Pestanoid A can be used for the study of osteoporosis ^[1].

HY-N11536

erythro-Austrobailignan-6	Structural Classification Saururaceae Saururus chinensis (Lour.) Baill. Source classification Lignans Phenylpropanoids Plants	Topoisomerase Apoptosis
erythro-Austrobailignan-6 is an orally active anti-cancer agent. erythro-Austrobailignan-6 inhibits DNA topoisomerase I and II activity. erythro-Austrobailignan-6 induces cell apoptosis and increases phosphorylation of p38 and JNK .

Cat. No.	Compare	Product Name	Species	Source

HY-P73848

	JNK1 Protein, Human (sf9, GST) Mitogen-activated protein kinase 8; MAPK 8; JNK-46; JNK1; PRKM8	Human	Sf9 insect cells
	JNK1 is a multifunctional serine/threonine protein kinase that complexly regulates multiple cellular processes, including cell proliferation, apoptosis, and differentiation. JNK1 is activated by MAP2K4/MKK4 and MAP2K7/MKK7, phosphorylates AP-1 components, and affects transcriptional activity. JNK1 Protein, Human (sf9, GST) is the recombinant human-derived JNK1 protein, expressed by Sf9 insect cells , with N-GST labeled tag. The total length of JNK1 Protein, Human (sf9, GST) is 427 a.a., with molecular weight of ~65 kDa.

Cat. No.	Product Name	Application	Reactivity

HY-P80728

JNK Antibody AI849689; c Jun N terminal kinase 1; C-JUN kinase 1; c-Jun N-terminal kinase 1; EC 2.7.11.24; JAK 1A; JAK1A; JNK 1; JNK 46; JNK; JNK-46; JNK1A2; JNK21B1/2; MAP kinase 8; MAPK 8; MAPK8; Mitogen activated protein kinase 8; Mitogen-activated protein kinase 8	WB, IP	Human, Mouse, Rat, Hamster
JNK Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48 kDa, targeting to JNK. It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat, Hamster.

HY-P80831

*Phospho-JNK1* (Thr183/Tyr185) Antibody** AI849689; c Jun N terminal kinase 1; C-JUN kinase 1; c-Jun N-terminal kinase 1; EC 2.7.11.24; JAK 1A; JAK1A; JNK 1; JNK 46; JNK; JNK-46; JNK1A2; JNK21B1/2; MAP kinase 8; MAPK 8; MAPK8; Mitogen activated protein kinase 8; Mitogen-activated protein kinase 8	WB, IP	Human, Rat
Phospho-JNK1 (Thr183/Tyr185) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48 kDa, targeting to Phospho-JNK1 (Thr183/Tyr185). It can be used for WB,IP assays with tag free, in the background of Human, Rat.

HY-P80729

JNK1 Antibody (YA720) AI849689; c Jun N terminal kinase 1; C-JUN kinase 1; c-Jun N-terminal kinase 1; EC 2.7.11.24; JAK 1A; JAK1A; JNK 1; JNK 46; JNK; JNK-46; JNK1A2; JNK21B1/2; MAP kinase 8; MAPK 8; MAPK8; Mitogen activated protein kinase 8; Mitogen-activated protein kinase 8	WB, ICC/IF	Human, Mouse, Rat
JNK1 (1A4) Antibody is a non-conjugated and Mouse origined monoclonal antibody about 48 kDa, targeting to JNK1 (1A4). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.

HY-P80198

JNK1+JNK3 Antibody	WB, IP	Mouse, Rat
JNK1+JNK3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48/53 kDa, targeting to JNK1+JNK3. It can be used for WB,IP assays with tag free, in the background of Mouse, Rat.

HY-P80197

JNK1+JNK2+JNK3 Antibody	WB, ICC/IF, IHC-P, IP	Human, Mouse, Rat
JNK1+JNK2+JNK3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48/53 kDa, targeting to JNK1+JNK2+JNK3. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inhibitors & Agonists

Fluorescent Dye

Biochemical Assay Reagents

Peptides

Natural
Products

Recombinant Proteins

Antibodies

JNK1

Inhibitors & Agonists

Fluorescent Dye

Biochemical Assay Reagents

Peptides

NaturalProducts

Recombinant Proteins

Antibodies

Natural
Products